Cornea A, Janovick J A, Lin X, Conn P M
Oregon Regional Primate Research Center, Beaverton 97006, USA.
Endocrinology. 1999 Sep;140(9):4272-80. doi: 10.1210/endo.140.9.7049.
The first step in GnRH signaling is binding by the peptide to its plasma membrane receptor (GnRHR). The receptor is a member of the seven transmembrane G protein-coupled class but lacks the characteristic C-terminal cytoplasmic tail, making it among the smallest receptors in this superfamily. It has been known since 1980 that agonist occupancy of the GnRHR results in patching, capping, and internalization, although it has not been possible to localize the unoccupied GnRHR, because elaboration of receptor antisera has not been easy to achieve. The recent production of a green fluorescent protein (GFP) conjugate of the GnRHR ("rGnRHR-C-tail-GFP") that is expressed in cells, targeted to the plasma membrane, binds GnRH analogs and couples to G proteins has made it possible to monitor movement of the unoccupied receptor by confocal microscopy. In the present study, we used this probe, along with Texas Red conjugates of a GnRH agonist, to examine simultaneous processing of the receptor and its ligands. The preparation of the GFP GnRHR chimera has been described. A Texas Red conjugate was made from the GnRH agonist D-Lys6-Pro9-des-Gly10EA-GnRH by standard procedures. Bioactivity of this conjugate was confirmed. Confocal fluorescence images of living GGH3 cells showed that the agonist binds the GFP-GnRH receptor construct on the cell membrane and causes the internalization of vesicles delimited by a membrane. Shortly after internalization, the agonist separates from receptor inside the vesicle, although it is still enclosed in membranes containing free receptor. As the vesicles approach the perinuclear space, the separation between receptor and agonist is more pronounced. Free receptor appears at the cell membrane after the internalization of agonist has been completed. The protein synthesis inhibitor, cycloheximide (1 mM) did not inhibit this process, suggesting that the free receptor results from the recycling of previously internalized vesicles rather than from newly synthesized receptor. These studies show visual evidence for recycling of the GnRH receptor in cultured cells.
促性腺激素释放激素(GnRH)信号传导的第一步是该肽与其质膜受体(GnRHR)结合。该受体是七跨膜G蛋白偶联家族的成员,但缺乏特征性的C末端细胞质尾巴,使其成为该超家族中最小的受体之一。自1980年以来就知道,GnRHR的激动剂占据会导致补丁形成、帽化和内化,尽管由于制备受体抗血清并不容易,所以一直无法定位未被占据的GnRHR。最近产生了一种在细胞中表达、靶向质膜、结合GnRH类似物并与G蛋白偶联的GnRHR绿色荧光蛋白(GFP)缀合物(“rGnRHR-C-尾-GFP”),这使得通过共聚焦显微镜监测未被占据受体的运动成为可能。在本研究中,我们使用该探针以及GnRH激动剂的德克萨斯红缀合物,来检查受体及其配体的同步处理过程。GFP GnRHR嵌合体的制备方法已作描述。通过标准程序由GnRH激动剂D-Lys6-Pro9-des-Gly10EA-GnRH制备了德克萨斯红缀合物。证实了该缀合物的生物活性。活的GGH3细胞的共聚焦荧光图像显示,激动剂与细胞膜上的GFP-GnRH受体构建体结合,并导致由膜界定的小泡内化。内化后不久,激动剂在小泡内与受体分离,尽管它仍被包含游离受体的膜包围。当小泡接近核周空间时,受体与激动剂之间的分离更加明显。激动剂内化完成后,游离受体出现在细胞膜上。蛋白质合成抑制剂环己酰亚胺(1 mM)并未抑制这一过程,这表明游离受体来自先前内化小泡的再循环,而非新合成的受体。这些研究为培养细胞中GnRH受体的再循环提供了直观证据。